A Study to Evaluate Safety, Tolerability, and Immunogenicity of V350A and V350B in Healthy Participants (V350-001).
Clinical trial NCT06655324 · RECRUITING
Trial details
- NCT number
- NCT06655324
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-05
- Primary completion
- 2028-07-17
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.